Company / Depreciation & Amortization
Relay Therapeutics, Inc. Depreciation & Amortization History
FY2019-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$3.5M
FY2022
5-year range
$2.8M / $3.5M
FY2019-FY2022
Trend
+24.7%
vs FY2021
Sector context
#83 of 163
Health Care
What the data says
At $4M, Relay Therapeutics, Inc.'s depreciation & amortization ranks #81 of 163 in the Health Care sector. Increased from $3M to $4M over the past 2 years.
Based on SEC 10-K filings.
$4M in FY2022 with a 3-year CAGR of +7.6%.
Increased from $3M to $4M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +7.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#81 of 163 in Health CareTop 49% of 163This company $3.5M Sector average $219.4M
▼
-98.4% below sector average
Key checks
Key Insights
- 3-year CAGR of +7.6%, indicating consistent growth.
- In FY2022, depreciation & amortization increased 24.7% year-over-year.
- Ranks #83 out of 163 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $3.5M | +24.7% |
| FY2021 | $2.8M | +0.0% |
| FY2020 | $2.8M | +0.0% |
| FY2019 | $2.8M | - |
As of FY2022 · SEC 10-K · Updated Jun 30, 2026